A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Assess The Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for The Treatment of Bacterial Vaginosis

Grant

Date/time Interval

  • January 18, 2018 - March 31, 2018
  • Awarded By

    Total Award Amount

  • 7500.00
  • Direct Costs

  • 5051.00
  • Sponsor Award Id

  • HHSN27200018
  • Contributor

  • Jane Schwebke   Principal Investigator